A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

NCT06299826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure

Interventions

DRUG: AZD5462
DRUG: Placebo

Sponsor

AstraZeneca